{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:37:31Z","timestamp":1790779051333,"version":"4.1.0"},"reference-count":109,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Human erythropoietin (EPO) is an N-linked glycoprotein consisting of 166 aa that is produced in the kidney during the adult life and acts both as a peptide hormone and hematopoietic growth factor (HGF), stimulating bone marrow erythropoiesis. EPO production is activated by hypoxia and is regulated via an oxygen-sensitive feedback loop. EPO acts via its homodimeric erythropoietin receptor (EPO-R) that increases cell survival and drives the terminal erythroid maturation of progenitors BFU-Es and CFU-Es to billions of mature RBCs. This pathway involves the activation of multiple erythroid transcription factors, such as GATA1, FOG1, TAL-1, EKLF and BCL11A, and leads to the overexpression of genes encoding enzymes involved in heme biosynthesis and the production of hemoglobin. The detection of a heterodimeric complex of EPO-R (consisting of one EPO-R chain and the CSF2RB \u03b2-chain, CD131) in several tissues (brain, heart, skeletal muscle) explains the EPO pleotropic action as a protection factor for several cells, including the multipotent MSCs as well as cells modulating the innate and adaptive immunity arms. EPO induces the osteogenic and endothelial transdifferentiation of the multipotent MSCs via the activation of EPO-R signaling pathways, leading to bone remodeling, induction of angiogenesis and secretion of a large number of trophic factors (secretome). These diversely unique properties of EPO, taken together with its clinical use to treat anemias associated with chronic renal failure and other blood disorders, make it a valuable biologic agent in regenerative medicine for the treatment\/cure of tissue de-regeneration disorders.<\/jats:p>","DOI":"10.3390\/cells10082140","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T08:44:45Z","timestamp":1629449085000},"page":"2140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine"],"prefix":"10.3390","volume":"10","author":[{"given":"Asterios S.","family":"Tsiftsoglou","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"ao111619","DOI":"10.1101\/cshperspect.a011619","article-title":"Erythropoietin","volume":"3","author":"Bunn","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000356193","article-title":"Physiology and Pharmacology of Erythropoietin","volume":"40","author":"Jelkman","year":"2013","journal-title":"Transfus. Med. Hemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1084\/jem.20122760","article-title":"Erythropoietin: Multiple targets, actions and modifying influences for biological and clinical considerations","volume":"210","author":"Broxmeyer","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/iub.226","article-title":"Erythropoiesis: Model systems, molecular regulation and developmental processes","volume":"61","author":"Tsiftsoglou","year":"2009","journal-title":"IUBMB Life"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bhoopalan, S.V., Jun-Huang, L., and Weiss, M.J. (2020). Erythropoietin regulation of red blood cell production: From bench to bedside and back. F1000Research, 9.","DOI":"10.12688\/f1000research.26648.1"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Suresh, S., de Castro, L.F., Robey, P.G., and Noguchi, C.T. (2019). Erythropoietin modulates bone marrow stromal cell differentiation. Bone Res., 7.","DOI":"10.1038\/s41413-019-0060-0"},{"key":"ref_7","first-page":"842","article-title":"Cloning, sequencing and evolutionary analysis of the mouse erythropoietin gene","volume":"6","author":"McDonald","year":"1986","journal-title":"Mol. Cell. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1073\/pnas.82.22.7580","article-title":"Cloning and expression of the human erythropoietin gene","volume":"82","author":"Lin","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","unstructured":"Eisele, A.S., Cosgrove, J., Magniez, A., Tubenf, E., Beuto, T., Cayrac, E., Tak, T., Lyne, A.M., Urbanus, J., and Perie, L. (2020). Erythropoietin directly affects single hematopoietic stem cell differentiation after transplantation. BioRxiv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V8.4.349.349","article-title":"Humoral regulation of red cell production","volume":"8","author":"Enlev","year":"1953","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/179633a0","article-title":"Role of kidney in erythropoiesis","volume":"179","author":"Jacobson","year":"1957","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/S0021-9258(19)63387-9","article-title":"Purification of human erythropoietin","volume":"252","author":"Miyake","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1073\/pnas.68.4.697","article-title":"Purification of erythropoietin","volume":"68","author":"Goldwasser","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0092-8674(89)90965-3","article-title":"Expression cloning of the mouse erythropoietin receptor","volume":"57","author":"Lodish","year":"1989","journal-title":"Cell"},{"key":"ref_15","first-page":"1","article-title":"Erythropoietin as a neuroprotective molecule: An overview of its therapeutic potential in neurodegenerative diseases","volume":"11","author":"Rey","year":"2019","journal-title":"Am. Soc. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine.42.142","article-title":"Pleiotropic functions of Erythropoietin","volume":"42","author":"Sasaki","year":"2003","journal-title":"Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3324\/haematol.2020.261966","article-title":"Hypoxia inducible erythropoietin expression: Details matter","volume":"105","author":"Kietzmann","year":"2020","journal-title":"Hematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-7428-3_7","article-title":"Functional analysis of erythroid progenitors by colony-forming assays","volume":"1698","author":"Palis","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Watts, D., Gaete, S., Rodriguez, D., Hoojewijs, D., Rauner, M., Sormendi, S., and Wielockx, B. (2020). Hypoxia pathway proteins are master regulators of erythropoiesis. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202010.0136.v1"},{"key":"ref_20","unstructured":"The Nobel Assembly at Karolinska Institutet (2019). Press Release: The Nobel Prize in Physiology or Medicine 2019, The Nobel Prize. Jointly to Kaelin, W.G.; Jr., Ratcliffe, P.J. and Semenza, C.l. for their discoveries of how cells sense and adapt to oxygen availability."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7150\/ijbs.9518","article-title":"Erythropoietin: A novel versatile player regulating Energy Metabolism and beyond the erythroid system","volume":"10","author":"Wang","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.stem.2012.02.003","article-title":"Endogenous BMMSCs are dynamic, fate restricted participants in bone maintenance and regeneration","volume":"10","author":"Park","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: Nature, biology and potential applications","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2014.08.011","article-title":"Stem cells and Bone. A historical perspective","volume":"70","author":"Bianco","year":"2015","journal-title":"Bone"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bone.2010.05.040","article-title":"Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta","volume":"47","author":"Li","year":"2010","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"584696","DOI":"10.3389\/fcell.2020.584696","article-title":"Effects of erythropoietin in white adipose tissue and bone microenvironment","volume":"8","author":"Suresh","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wan, L., Zhang, F., He, Q., Tsang, W.P., and Lu, L. (2014). EPO promotes bone repair through enhanced cartilaginous callus and angiogenesis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102010"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/ajt.15369","article-title":"Erythropoietin, a multifaceted protein with innate and adaptive modulatory activity","volume":"19","author":"Cantarelli","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41419-020-2276-8","article-title":"Erythropoietin and its derivatives: From tissue protection to immune regulation","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yuan, R., Maeda, Y., Li, W., Lu, W., Cook, S., and Dowing, P. (2008). Erythropoietin: A potent inducer of peripheral immune\/inflammatory modulation in autoimmune EAE. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001924"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"151041","DOI":"10.1016\/j.ejcb.2019.04.002","article-title":"Mesenchymal stem cell therapy for the treatment of inflammatory disease: Challenges, opportunities and future perspectives","volume":"98","author":"Regmi","year":"2019","journal-title":"Eur. J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kimakova, P., Solar, P., Solarova, Z., Komel, R., and Debeljak, N. (2017). Erythropoietin and its angiogenic activity. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071519"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ki.1995.113","article-title":"Recombinant human erythropoietin stimulates angiogenesis in vitro","volume":"47","author":"Carlini","year":"1995","journal-title":"Kidney Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.91.9.3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells","volume":"91","author":"Anagnostou","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a proangiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bone.2011.08.004","article-title":"Erythropoietin stimulates bone formation, cell proliferation and angiogenesis in a femoral segmented defect model in mice","volume":"49","author":"Holstein","year":"2011","journal-title":"Bone"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","article-title":"Mesenchymal stem cells can be differentiated into endothelial cells in vitro","volume":"22","author":"Oswald","year":"2004","journal-title":"Stem Cells"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1089\/scd.2015.0197","article-title":"Angiogenic potential and Secretome of human Apical Papilla Mesenchymal stem cells in Various Stress microenvironment","volume":"24","author":"Bakopoulou","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.archoralbio.2018.09.001","article-title":"Erythropoietin (rhEPOa) promotes endothelial transdifferentiation of stem cells of the apical papilla","volume":"96","author":"Koutsoumparis","year":"2018","journal-title":"Arch. Oral Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/EJE-09-0342","article-title":"Activation of the erythropoietin receptor in human skeletal muscle","volume":"161","author":"Rundqvist","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","first-page":"50","article-title":"Erythropoietin treatment enhances muscle mitochondrial capacity in humans","volume":"3","author":"Pledge","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1096\/fj.11-196618","article-title":"Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage","volume":"23","author":"Jia","year":"2012","journal-title":"FASEB J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13287-016-0394-0","article-title":"Secreted trophic factors of mesenchymal stem cells support neovascular and musculoskeletal therapies","volume":"7","author":"Hofer","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/scrt111","article-title":"Mesenchymal stem cell therapy for attenuation of scar formation during wound healing","volume":"3","author":"Jackson","year":"2012","journal-title":"Stem Cell Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jacc.2005.03.044","article-title":"Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infraction","volume":"46","author":"Lipsic","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","first-page":"799","article-title":"Limitation of infract size by erythropoietin is associated with translocation of AKT to the mitochondria after reperfusion","volume":"135","author":"Kobayashi","year":"2008","journal-title":"Clin. Exp. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium-reperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvinio","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.CIR.0000078635.89229.8A","article-title":"Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia reperfusion injury","volume":"108","author":"Cai","year":"2003","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI18200","article-title":"A novel protective effect of erythropoietin in the infracted heart","volume":"112","author":"Parsa","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1523\/JNEUROSCI.4480-05.2006","article-title":"A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery","volume":"26","author":"Tsai","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/rme.14.30","article-title":"Mesenchymal stem therapy for the treatment of amyotrophic lateral sclerosis: Signals for hope","volume":"9","author":"Allers","year":"2014","journal-title":"Regen. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41398-020-0697-x","article-title":"Delaying memory decline: Different options and emergency solutions","volume":"10","author":"Schneider","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fphys.2019.01534","article-title":"The many facets of erythropoietin Physiologic and Metabolic Response","volume":"10","author":"Suresh","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.biocel.2013.03.007","article-title":"Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-alpha and AMPK activation","volume":"45","author":"Wang","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"32395","DOI":"10.1074\/jbc.272.51.32395","article-title":"Regulated human erythropoietin receptor expression in mouse brain","volume":"272","author":"Liu","year":"1977","journal-title":"J. Chem. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.archoralbio.2010.12.008","article-title":"Comparative analysis of in vitro osteogenic\/odontogenic differentiation potential of human dental pulp stem cells (DPSCs) and stem cells from the apical papilla (SCAP)","volume":"56","author":"Bakopoulou","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J. Orthop. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Procop","year":"1997","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1242\/jcs.113.7.1161","article-title":"Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hieraxhical model","volume":"113","author":"Muraglia","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stromal cells in health and disease","volume":"8","author":"Ucelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria defining multipotent mesenchymal stromal cells. The International Society for Cell Therapy position statement","volume":"8","author":"Domenici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm3049","article-title":"The elusive nature and function of mesenchymal stem cells","volume":"12","author":"Ritz","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-62703-508-8_8","article-title":"Primary marrow derived stromal cells: Isolation and manipulation","volume":"1035","author":"Ramakrishan","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1096\/fj.202000888R","article-title":"Erythropoietin signaling in osteoblasts is required for normal bone formation and the bone loss during erythropoietin \u2013stimulated erythropoiesis","volume":"34","author":"Suresh","year":"2020","journal-title":"FASEB"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1073\/pnas.87.15.5978","article-title":"Erythropoietin has a mitogenic and positive chemotactic effect on endothial cells","volume":"87","author":"Anagnostou","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","article-title":"Erythropoietin and hypoxia stimulate erythropoietin-receptor and nitric oxide production by endothelial cells","volume":"104","author":"Cokic","year":"2004","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fimmu.2019.01112","article-title":"Multiplicity of mesenchymal stromal cells: Finding the right route to therapy","volume":"10","author":"Wilson","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_74","first-page":"393","article-title":"The development of fibroblastic colonies in monolayer cultures of guinea pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/hum.2010.136","article-title":"Mesenchymal stem cells in human bone marrow (skeletal stem cells): A critical discussion of their nature, identity and significance in incurable skeletal disease","volume":"21","author":"Bianco","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_76","unstructured":"Somoza, R.R., Corren, D., and Caplan, A.I. Role of mesenchymal stem cells as medicinal sighting cells Nature Protocols (poster)."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/stem.1681","article-title":"The surface markers and identity of Human Mesenchymal Stem cells","volume":"32","author":"Lv","year":"2014","journal-title":"Stem Cells"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41598-018-37981-x","article-title":"Comparative in vitro study of the osteogenic and adipogenic potential of human dental pulp stem cells, gingival fibroblasts and foreskin fibroblasts","volume":"9","author":"Monterubbianesi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1634\/stemcells.2007-0979","article-title":"Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues","volume":"26","author":"Arthur","year":"2008","journal-title":"Stem Cells"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.2008.02024.x","article-title":"Erythropoietin mediated tissue protection reducing collateral damage from the primary injury response","volume":"264","author":"Brines","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/cc2897","article-title":"Science review: Recombinant human erythropoietin in critical illness: A role beyond anemia?","volume":"8","author":"Coleman","year":"2004","journal-title":"Crit. Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_83","first-page":"F360","article-title":"Erythropoietin enhances recovery from cis-platinum\u2013induced acute renal failure","volume":"266","author":"Vaziri","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ki.2011.473","article-title":"Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury","volume":"81","author":"Cassis","year":"2012","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1600-6143.2010.03142.x","article-title":"High dose of epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF study","volume":"10","author":"Martinez","year":"2010","journal-title":"Am. J. Transpl."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40259-018-0262-9","article-title":"Epoetin biosimilars in the treatment of chemotherapy induced anemia: 10 years\u2019 experience gained","volume":"32","author":"Aapro","year":"2018","journal-title":"Biodrugs"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.leukres.2019.03.006","article-title":"Epoetin alfa for the treatment of myelodysplastic syndrome related anemia: A review of clinical data, clinical guidelines and treatment protocols","volume":"81","author":"Garson","year":"2019","journal-title":"Leuk. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11095-010-0288-2","article-title":"Quality of original and Biosimilar Epoetins Products","volume":"28","author":"Brinks","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_89","unstructured":"Editor Comment (2014). Biosimilars of Epoietin Alpha, Generics and Biosimilar Initiative GaBi."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drudis.2011.08.001","article-title":"The regulatory framework of biosimilars in the European Union","volume":"17","author":"Minghetti","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_91","first-page":"209","article-title":"Development and regulation of biosimilars: Current status and future challenges","volume":"7","author":"Tsiftsoglou","year":"2013","journal-title":"Biodrugs"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nbt.2322","article-title":"In support of the European Union Biosimilar framework","volume":"30","author":"Schneider","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40259-014-0109-y","article-title":"Demonstration of biosimilarity, extrapolation of indications and other challenges related to Biosimilars in Europe","volume":"28","author":"Tsiftsoglou","year":"2014","journal-title":"Biodrugs"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"39754","DOI":"10.1074\/jbc.M004999200","article-title":"Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts","volume":"275","author":"Ogilvie","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_95","first-page":"725","article-title":"The meaning, the sense and the significance translating the science of mesenchymal stem cells into medicine","volume":"107","author":"Bianco","year":"1999","journal-title":"Nat. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13578-020-00492-2","article-title":"Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerates the repair of acute kidney injury","volume":"10","author":"Zhou","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13287-015-0095-0","article-title":"Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease","volume":"6","author":"Wang","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Perucca, S., Di Palma, A., Piccaluga, P.P., Gemelli, C., Zoratti, E., Bassi, G., Giacopuzzi, E., Lojacono, A., Borsani, G., and Tagliafico, E. (2017). Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood hematopoietic stem cells (CB-CD34+ cells). PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172430"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21200","article-title":"Adult mesenchymal stem cells for tissue engineering versus regenerative medicine","volume":"213","author":"Caplan","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"11631172","DOI":"10.1089\/ten.tea.2014.0058","article-title":"Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel like-structures in vitro","volume":"21","author":"Yuan","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Yang, J.W., Shin, Y.Y., Seo, Y., and Kim, H.S. (2020). Therapeutic functions of stem cells from oral cavity: An update. Intern. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124389"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.reth.2019.12.011","article-title":"Mesenchymal stem cell-based tissue regeneration therapies for periodontitis","volume":"14","author":"Ouchi","year":"2020","journal-title":"Regen. Ther."},{"key":"ref_103","first-page":"7593402","article-title":"Dental stem cell derived secretome conditioned medium: The future for regenerative therapeutics applications","volume":"2020","author":"Radwan","year":"2020","journal-title":"Stem Cell Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biomaterials.2016.09.029","article-title":"Exosomes as biomimetic tools from stem cell differentiation: Applications in dental pulp tissue regeneration","volume":"111","author":"Huang","year":"2016","journal-title":"Biomaterials"},{"key":"ref_105","first-page":"2582080","article-title":"The angiogenic potential of DPScs and SCSPs in an in vivo Model of Dental Pulp Regeneration","volume":"2017","author":"Hillkens","year":"2017","journal-title":"Stem Cell Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1089\/scd.2014.0510","article-title":"Dental stem Cells in pulp regeneration: Near future or long road ahead","volume":"34","author":"Hillkens","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrd3052","article-title":"Challenges with Advanced Therapy Medicinal products and how to meet them","volume":"9","author":"Schneider","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtm.2019.01.010","article-title":"EU Regulatory Pathways for ATMPs: Standard, Accelerated and adaptive Pathways for Marketing Authorization","volume":"13","author":"Detela","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/rme.14.65","article-title":"Manufacturing, characterization and control of cell based medicinal products: Challenges paradigms toward commercial use","volume":"10","author":"Salmikangas","year":"2015","journal-title":"Regen. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/8\/2140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:47:43Z","timestamp":1760165263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/8\/2140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":109,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["cells10082140"],"URL":"https:\/\/doi.org\/10.3390\/cells10082140","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}